Immunovant, Inc.

NasdaqGS:IMVT Rapporto sulle azioni

Cap. di mercato: US$4.0b

Immunovant Proprietà

Chi sono i principali azionisti e gli insider hanno acquistato o venduto?

Recenti transazioni insider

NasdaqGS:IMVT Recenti transazioni di insider da parte di aziende o persone fisiche
DataValoreNomeEntitàRuoloAzioniPrezzo massimo
20 Nov 24SellUS$106,228Eva BarnettIndividual4,174US$25.45
20 Nov 24SellUS$85,334William MaciasIndividual3,353US$25.45
20 Nov 24SellUS$424,811Peter SalzmannIndividual16,692US$25.45
20 Nov 24SellUS$92,893Mark LevineIndividual3,650US$25.45
23 Oct 24SellUS$80,912Jay StoutIndividual2,740US$29.53
23 Oct 24SellUS$94,171Michael GeffnerIndividual3,189US$29.53
23 Oct 24SellUS$128,780Mark LevineIndividual4,361US$29.53
16 Oct 24SellUS$94,172Eva BarnettIndividual3,271US$28.79
16 Oct 24SellUS$91,783William MaciasIndividual3,188US$28.79
16 Oct 24SellUS$82,339Mark LevineIndividual2,860US$28.79
16 Oct 24SellUS$261,845Peter SalzmannIndividual9,095US$28.79
09 Oct 24SellUS$131,838Peter SalzmannIndividual4,460US$29.56
09 Oct 24SellUS$152,589Eva BarnettIndividual5,162US$29.56
21 Aug 24SellUS$480,052Peter SalzmannIndividual15,068US$32.32
21 Aug 24SellUS$120,045Eva BarnettIndividual3,768US$32.32
21 Aug 24SellUS$96,437Julia ButchkoIndividual3,027US$32.32
21 Aug 24SellUS$96,437William MaciasIndividual3,027US$32.32
21 Aug 24SellUS$104,976Mark LevineIndividual3,295US$32.32
24 Jul 24SellUS$111,456Mark LevineIndividual4,015US$27.76
24 Jul 24SellUS$95,939Michael GeffnerIndividual3,456US$27.76
24 Jul 24SellUS$78,089Jay StoutIndividual2,813US$27.76
17 Jul 24SellUS$257,888Peter SalzmannIndividual8,685US$30.55
17 Jul 24SellUS$85,132Julia ButchkoIndividual2,867US$30.55
17 Jul 24SellUS$92,733Eva BarnettIndividual3,123US$30.55
17 Jul 24SellUS$90,386William MaciasIndividual3,044US$30.55
17 Jul 24SellUS$74,382Mark LevineIndividual2,505US$30.55
09 Jul 24SellUS$129,609Peter SalzmannIndividual4,619US$28.06
09 Jul 24SellUS$42,848Julia ButchkoIndividual1,527US$28.06
09 Jul 24SellUS$133,201Eva BarnettIndividual4,747US$28.06
22 May 24SellUS$96,125Mark LevineIndividual3,242US$29.65
22 May 24SellUS$96,274William MaciasIndividual3,247US$29.65
22 May 24SellUS$96,274Julia ButchkoIndividual3,247US$29.65
22 May 24SellUS$479,233Peter SalzmannIndividual16,163US$29.65
22 May 24SellUS$119,845Eva BarnettIndividual4,042US$29.65
24 Apr 24SellUS$114,531Mark LevineIndividual3,963US$28.90
24 Apr 24SellUS$94,243Michael GeffnerIndividual3,261US$28.90
24 Apr 24SellUS$209,207Jay StoutIndividual7,239US$28.90
17 Apr 24SellUS$990,269Peter SalzmannIndividual34,079US$29.94
17 Apr 24SellUS$293,923Julia ButchkoIndividual10,115US$29.94
17 Apr 24SellUS$285,554Mark LevineIndividual9,827US$29.94
17 Apr 24SellUS$356,049Eva BarnettIndividual12,253US$29.94
17 Apr 24SellUS$240,602William MaciasIndividual8,280US$29.94
09 Apr 24SellUS$149,882Peter SalzmannIndividual4,807US$31.18
09 Apr 24SellUS$115,023Eva BarnettIndividual3,689US$31.18
09 Apr 24SellUS$32,833Julia ButchkoIndividual1,053US$31.18
22 Feb 24SellUS$486,362Peter SalzmannIndividual13,454US$36.15
22 Feb 24SellUS$77,144Mark LevineIndividual2,134US$36.15
22 Feb 24SellUS$77,578Julia ButchkoIndividual2,146US$36.15
22 Feb 24SellUS$80,289William MaciasIndividual2,221US$36.15
22 Feb 24SellUS$105,920Eva BarnettIndividual2,930US$36.15
26 Jan 24SellUS$114,778Mark LevineIndividual3,027US$38.45
26 Jan 24SellUS$383,012Michael GeffnerIndividual10,101US$38.45
18 Jan 24SellUS$17,397William MaciasIndividual424US$41.03
11 Jan 24SellUS$147,023Eva BarnettIndividual3,515US$42.43
05 Jan 24SellUS$147,568Peter SalzmannIndividual3,824US$38.59
05 Jan 24SellUS$50,051Julia ButchkoIndividual1,297US$38.59
01 Dec 23SellUS$490,668Atul PandeIndividual12,350US$40.46

Volume di insider trading

Acquisto da parte di insider: IMVT insider hanno venduto azioni solo negli ultimi 3 mesi.

Ripartizione della proprietà

Qual è l'assetto proprietario di IMVT?
Tipo di proprietarioNumero di azioniPercentuale di proprietà
Singoli insider1.335.1140,828%
Aziende pubbliche79.805.33149,5%
Istituzioni80.011.26149,6%

Diluizione delle azioni: Gli azionisti non sono stati significativamente diluiti nell'ultimo anno.

I principali azionisti

I primi 25 azionisti possiedono 96.95% della società
ProprietàNomeAzioniValore attualeVariazione %Portafoglio %
54,4%
Roivant Sciences Ltd.
79.805.331US$2.2b0%Nessun dato
8,54%
FMR LLC
12.537.561US$340.5m19,6%0,02%
4,54%
The Vanguard Group, Inc.
6.658.800US$180.9m2,29%Nessun dato
3,44%
BlackRock, Inc.
5.053.150US$137.2m2,79%Nessun dato
3,09%
T. Rowe Price Group, Inc.
4.540.063US$123.3m52%0,01%
2,96%
Deep Track Capital, LP
4.347.464US$118.1m50,8%3,51%
2,42%
Armistice Capital LLC
3.548.000US$96.4m4,45%2,4%
2,06%
State Street Global Advisors, Inc.
3.022.342US$82.1m11,2%Nessun dato
1,62%
Perceptive Advisors LLC
2.378.762US$64.6m23,7%1,38%
1,58%
Viking Global Investors LP
2.320.902US$63.0m0%0,21%
1,28%
Alpine Global Management, LLC
1.882.704US$51.1m-1,31%13,41%
1,03%
Geode Capital Management, LLC
1.510.926US$41.0m6,85%Nessun dato
0,96%
Woodline Partners LP
1.414.977US$38.4m-22,4%0,31%
0,93%
Paradigm Biocapital Advisors LP
1.362.827US$37.0m0%1,26%
0,84%
Pictet Asset Management Limited
1.230.309US$33.4m4,72%0,03%
0,83%
Baker Bros. Advisors LP
1.225.410US$33.3m164%0,3%
0,83%
Rock Springs Capital Management LP
1.221.309US$33.2m3,01%1,08%
0,78%
Hood River Capital Management LLC
1.143.567US$31.1m0%0,44%
0,77%
ADAR1 Capital Management, LLC
1.131.707US$30.7m137%5,25%
0,75%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1.104.910US$30.0m27,7%0,01%
0,75%
Logos Global Management, L.P.
1.100.000US$29.9m91,3%3,44%
0,69%
Franklin Resources, Inc.
1.017.396US$27.6m-1,55%0,01%
0,67%
Capital Research and Management Company
976.237US$26.5m0%Nessun dato
0,65%
Principal Global Investors, LLC
951.124US$25.8m69,9%0,01%
0,56%
Tavistock Life Sciences
825.000US$22.4m0%1,4%